Eric K Rowinsky Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eric K Rowinsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eric K Rowinsky. Eric K Rowinsky is Chief Medical Officer in IMCLONE SYSTEMS INC ($IMCLE) and SVP, CHIEF MEDICAL OFFICER in IMCLONE SYSTEMS INC ($IMCLE) and Director in BIOGEN INC. ($IDPH) and Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Chief Medical Officer in STEMLINE THERAPEUTICS INC ($STML) and Director in BIND Therapeutics, Inc ($BIND) and Director in Fortress Biotech, Inc. ($FBIO) and Director in Verastem, Inc. ($VSTM).
Latest Insider Trading Transactions of Eric K Rowinsky
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, BIND, FBIO, IMCLE, NAVB, STML, VSTM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.45 | 10,000 | 44,500 | 720,000 | 730 K to 720 K (-1.37 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.31 | 8,000 | 34,480 | 730,000 | 738 K to 730 K (-1.08 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 4.20 | 6,000 | 25,200 | 738,000 | 744 K to 738 K (-0.81 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 3.86 | 2,000 | 7,720 | 744,000 | 746 K to 744 K (-0.27 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Sell | S | 3.80 | 4,000 | 15,200 | 746,000 | 750 K to 746 K (-0.53 %) |
Apr 09 2021 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 750,000 | 650 K to 750 K (+15.38 %) |
Jun 18 2020 | VSTM | Verastem, Inc. | Rowinsky Eric K | Director | Option Exercise | A | 1.77 | 25,000 | 44,250 | 25,000 | |
Jun 05 2020 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 890 | 0 | 17,069 | 16.2 K to 17.1 K (+5.50 %) |
Mar 13 2020 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 650,000 | 550 K to 650 K (+18.18 %) |
Jun 25 2019 | VSTM | Verastem, Inc. | Rowinsky Eric K | Director | Option Exercise | A | 1.81 | 25,000 | 45,250 | 25,000 | |
Jun 25 2019 | VSTM | Verastem, Inc. | Rowinsky Eric K | Director | Option Exercise | A | 1.81 | 25,000 | 45,250 | 25,000 | |
Jun 20 2019 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 1,155 | 0 | 16,179 | 15 K to 16.2 K (+7.69 %) |
Apr 12 2019 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 550,000 | 450 K to 550 K (+22.22 %) |
Nov 30 2018 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 450,000 | 350 K to 450 K (+28.57 %) |
Jun 14 2018 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 880 | 0 | 15,024 | 14.1 K to 15 K (+6.22 %) |
Feb 22 2018 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 173,764 | |
Feb 22 2018 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 50 | 341,446 | 291.4 K to 341.4 K (+17.16 %) |
Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Option Exercise | A | 0.75 | 50,000 | 37,500 | 50,000 | |
Jun 30 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 50 | 291,446 | 241.4 K to 291.4 K (+20.71 %) |
Jun 15 2017 | VSTM | Verastem, Inc. | Rowinsky Eric K | Director | Option Exercise | A | 2.09 | 50,000 | 104,500 | 50,000 | |
Jun 09 2017 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 1,055 | 0 | 14,144 | 13.1 K to 14.1 K (+8.06 %) |
Jan 24 2017 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 350,000 | 250 K to 350 K (+40.00 %) |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowinsky Eric K | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
Aug 30 2016 | BIND | DNIB UNWIND, INC. | Rowinsky Eric K | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
Jun 22 2016 | BIND | BIND Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
Jun 09 2016 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 1,060 | 0 | 13,065 | 12 K to 13.1 K (+8.83 %) |
Apr 29 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 28,000 | 0 | 224,446 | 196.4 K to 224.4 K (+14.25 %) |
Apr 29 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 1.14 | 10,726 | 12,228 | 196,446 | 185.7 K to 196.4 K (+5.78 %) |
Jan 05 2016 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 100,000 | 0 | 250,000 | 150 K to 250 K (+66.67 %) |
Jun 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Grant | A | 0.00 | 695 | 0 | 12,005 | 11.3 K to 12 K (+6.15 %) |
Jun 10 2015 | BIND | BIND Therapeutics, ... | Rowinsky Eric K | Director | Option Exercise | A | 5.87 | 15,000 | 88,050 | 15,000 | |
Apr 28 2015 | STML | STEMLINE THERAPEUT ... | Rowinsky Eric K | Chief Medical Offic ... | Sell | S | 15.77 | 10,824 | 170,694 | 143,688 | 154.5 K to 143.7 K (-7.01 %) |
Mar 30 2015 | NAVB | NAVIDEA BIOPHARMAC ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 22,000 | 0 | 185,720 | 163.7 K to 185.7 K (+13.44 %) |
Mar 23 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 11,667 | 697,920 | 0 | |
Mar 23 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 475.00 | 11,667 | 5,541,825 | 11,310 | 23 K to 11.3 K (-50.78 %) |
Mar 23 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 11,667 | 697,920 | 22,977 | 11.3 K to 23 K (+103.16 %) |
Mar 20 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 2,333 | 139,560 | 11,667 | |
Mar 20 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 436.14 | 2,333 | 1,017,508 | 11,310 | 13.6 K to 11.3 K (-17.10 %) |
Mar 20 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 2,333 | 139,560 | 13,643 | 11.3 K to 13.6 K (+20.63 %) |
Mar 18 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 4,667 | 279,180 | 14,000 | |
Mar 18 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 425.45 | 4,667 | 1,985,589 | 11,310 | 16 K to 11.3 K (-29.21 %) |
Mar 18 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 4,667 | 279,180 | 15,977 | 11.3 K to 16 K (+41.26 %) |
Mar 16 2015 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 0 | 150,000 | 100 K to 150 K (+50.00 %) |
Mar 16 2015 | FBIO | Fortress Biotech, ... | Rowinsky Eric K | Director | Grant | A | 0.00 | 50,000 | 0 | 100,000 | 50 K to 100 K (+100.00 %) |
Mar 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Option Exercise | M | 59.82 | 4,666 | 279,120 | 18,667 | |
Mar 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Sell | S | 417.23 | 4,666 | 1,946,795 | 11,310 | 16 K to 11.3 K (-29.21 %) |
Mar 11 2015 | IDPH | BIOGEN INC. | Rowinsky Eric K | Director | Buy | M | 59.82 | 4,666 | 279,120 | 15,976 | 11.3 K to 16 K (+41.26 %) |
Mar 10 2015 | STML | STEMLINE THERAPEUT ... | Rowinsky Eric K | Chief Medical Offic ... | Option Exercise | A | 15.75 | 69,201 | 1,089,916 | 69,201 | |
Mar 10 2015 | STML | STEMLINE THERAPEUT ... | Rowinsky Eric K | Chief Medical Offic ... | Grant | A | 0.00 | 24,379 | 0 | 154,512 | 130.1 K to 154.5 K (+18.73 %) |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 2,000 | 0 | 2,000 | |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | M | 0.00 | 2,667 | 0 | 0 | |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Payment of Exercise | F | 39.06 | 893 | 34,881 | 1,774 | 2.7 K to 1.8 K (-33.48 %) |
Feb 20 2008 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Buy | M | 0.00 | 2,667 | 0 | 2,667 | 0 to 2.7 K |
Feb 20 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 2,667 | 0 | 8,000 | |
Feb 20 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 2,667 | 0 | 5,333 | |
Feb 20 2007 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 2,666 | 0 | 2,666 | |
Jan 23 2006 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, CHIEF MEDICAL ... | Option Exercise | A | 34.14 | 8,333 | 284,489 | 25,000 | |
Jan 23 2006 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, CHIEF MEDICAL ... | Option Exercise | A | 34.14 | 8,333 | 284,489 | 16,667 | |
Jan 23 2006 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | SVP, CHIEF MEDICAL ... | Option Exercise | A | 34.14 | 8,334 | 284,523 | 8,334 | |
Feb 24 2005 | IMCLE | IMCLONE SYSTEMS IN ... | Rowinsky Eric K | Chief Medical Offic ... | Option Exercise | A | 42.52 | 75,000 | 3,189,000 | 75,000 |
Page: 1